Opportunity Information: Apply for PAR 25 178
The National Institutes of Health, through the National Institute of Mental Health (NIMH), is offering an R01 grant opportunity titled "Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 Clinical Trial Required)" (Funding Opportunity Number PAR 25-178; CFDA 93.242). This program supports early-stage, real-world clinical trials that sit at the intersection of effectiveness research (does an intervention work in routine practice settings and diverse populations?) and implementation research (how can it be delivered well, consistently, and at scale in those settings?). The focus is on pilot-level hybrid trials, meaning projects are expected to generate practical evidence about both outcomes and delivery, while still being appropriately scoped as pilots rather than full-scale definitive effectiveness trials.
The scientific purpose centers on advancing NIMH's clinical trials "pipeline" by funding studies that either (1) improve and adapt preventive or therapeutic interventions that have already shown efficacy, so they can perform well with broader populations or in community practice environments, or (2) develop and conduct preliminary testing of innovative mental health services interventions. In practice, this means applicants can propose work such as adapting an evidence-based therapy to better fit primary care, schools, community clinics, or other routine service settings; testing strategies to improve reach, engagement, continuity, or quality of care; or piloting new service delivery models that address access, coordination, or provider behavior in mental health systems.
A key requirement is alignment with NIMH's experimental therapeutics approach. Projects are expected to go beyond asking whether an intervention helps; they must also explicitly test whether the intervention engages its intended target(s) or mechanism(s) that are presumed to drive meaningful change. Those targets might include clinical or functional mechanisms (for example, measurable changes in symptoms, functioning, cognition, emotion regulation, or related processes), as well as service and implementation mechanisms (for example, changes in provider behavior, fidelity to care processes, patient engagement, improved access, better continuity, or other measurable system-level pathways). In other words, the trial design should be built to evaluate both outcomes and whether the hypothesized mechanism was actually affected, so that results can inform future optimization and scaling decisions.
This opportunity is categorized as discretionary funding and uses the NIH grant mechanism (R01). It is explicitly a clinical trial required announcement, so proposed projects must meet NIH's definition of a clinical trial and include appropriate trial methods and protections (for example, clear intervention and comparison conditions, outcomes, and a plan for human subjects oversight consistent with NIH expectations). While the announcement emphasizes pilot studies, the intent is that results will be strong enough to justify next-step research, such as a larger effectiveness trial, a more advanced hybrid effectiveness-implementation study, or a broader implementation effort.
Eligibility is broad and includes many types of U.S. organizations and governmental entities. Eligible applicants include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; Native American tribal governments (federally recognized); public housing authorities and Indian housing authorities; Native American tribal organizations (other than federally recognized tribal governments); nonprofit organizations with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); and small businesses. The notice also highlights additional eligible groups such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-U.S. (foreign) entities.
The opportunity was created on 2024-11-26 and lists an original closing date of 2027-10-15. Some award details such as an explicit award ceiling and the expected number of awards are not specified in the provided source text, which typically means applicants should consult the full NOFO for budget expectations, allowed project periods, and any institute-specific caps or guidance. Overall, the program is designed for teams that can run a rigorous, mechanism-focused pilot clinical trial in real-world settings, with an eye toward producing actionable findings about both mental health outcomes and the practical conditions needed for successful delivery.Apply for PAR 25 178
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
- This funding opportunity was created on 2024-11-26.
- Applicants must submit their applications by 2027-10-15.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
Previous opportunity: The Nita M. Lowey Middle East Partnership for Peace Act (MEPPA)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 25 178
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 25 178) also looked into and applied for these:
| Funding Opportunity |
|---|
| First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required) Apply for PAR 25 180 Funding Number: PAR 25 180 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required) Apply for PAR 25 182 Funding Number: PAR 25 182 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required) Apply for PAR 25 181 Funding Number: PAR 25 181 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Health Services Research (R34 Clinical Trial Optional) Apply for PAR 25 192 Funding Number: PAR 25 192 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required) Apply for PAR 25 193 Funding Number: PAR 25 193 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Health Services Research (R01 Clinical Trial Optional) Apply for PA 25 245 Funding Number: PA 25 245 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required) Apply for PA 25 163 Funding Number: PA 25 163 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Artificial Intelligence in Pre-clinical Drug Development for AD/ADRD (R01 Clinical Trial Not Allowed) Apply for RFA AG 24 049 Funding Number: RFA AG 24 049 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) Apply for PAR 25 188 Funding Number: PAR 25 188 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems (UG3/UH3 Clinical Trials Not Allowed Apply for RFA RM 24 012 Funding Number: RFA RM 24 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required) Apply for PAR 25 216 Funding Number: PAR 25 216 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed) Apply for PAR 25 215 Funding Number: PAR 25 215 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required) Apply for PAR 25 271 Funding Number: PAR 25 271 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) Apply for PAR 25 270 Funding Number: PAR 25 270 Agency: National Institutes of Health Category: Health Funding Amount: $1,050,000 |
| Targeting Cell Surface HIV Envelope for Cell Elimination (R01 Clinical Trial Not Allowed) Apply for PAR 25 300 Funding Number: PAR 25 300 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) Apply for PAR 25 269 Funding Number: PAR 25 269 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| PEPFAR Community Led Monitoring (CLM)-Zambia Apply for PCLM 2025 Funding Number: PCLM 2025 Agency: U.S. Mission to Zambia Category: Health Funding Amount: $115,000 |
| USAID SUstaining Control of the HIV Epidemic through quality Services, resilient Systems, and Community Outreach (SUCESSO) _ Sofala & Niassa Apply for 72065625RFA00002 Funding Number: 72065625RFA00002 Agency: Mozambique USAID-Maputo Category: Health Funding Amount: $77,500,000 |
| NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) Apply for PAR 25 251 Funding Number: PAR 25 251 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| USAID Sustaining Control of the HIV Epidemic through quality Services, resilient systems, and Community Outreach (SUCESSO) - Tete & Manica Apply for 72065625RFA00005 Funding Number: 72065625RFA00005 Agency: Mozambique USAID-Maputo Category: Health Funding Amount: $77,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 25 178", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
